Tirzepatide 2mg -120mg| >99% Purity| Weight Loss Peptide

(7)
36.00
49.00
Chemical Specifications
Product Name Tirzepatide
CAS Number 2023788-19-2
Molecular Formula C225H348N48O68
Molecular Weight 4813.5 g/mol
Purity (HPLC) ≥ 99.0%
Appearance White Lyophilized Powder
Storage Store at -20°C (Protect from light and moisture)
        SPECIAL OFFER

          Please select all product options

          Product was out of stock

          share
          Description
          🔬

          What is Tirzepatide?

          Tirzepatide (5mg – 30mg Vials) is a revolutionary, first-in-class synthetic peptide engineered as a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. This highly advanced compound is a 39-amino acid modified peptide that synergistically targets multiple metabolic pathways. It serves as a premier, high-grade research tool for investigating breakthrough therapies in obesity, profound weight management, and advanced type 2 diabetes metabolic models.

          Key Features & Research Benefits

          🩸

          Glycemic Regulation (Type 2 Diabetes)

          Provides a highly robust mechanism for blood glucose management. The dual receptor activation significantly enhances glucose-dependent insulin secretion and suppresses glucagon, making it a premier compound for advancing Type 2 Diabetes models.

          📉

          Potent Weight Reduction (Obesity)

          Demonstrates extraordinary efficacy in research models for extreme body mass reduction. By powerfully amplifying central satiety signaling and delaying gastric emptying, it serves as the ultimate compound for studying severe obesity.

          ❤️

          Cardiovascular & Metabolic Benefits

          Beyond weight and glucose control, research shows comprehensive improvements in systemic metabolic markers. It offers vital insights into lipid profile optimization, blood pressure regulation, and broad cardiovascular protective mechanisms.

          🧬

          Dual GIP & GLP-1 Agonism

          Uniquely engineered as a “twincretin” to simultaneously activate both GIP and GLP-1 receptors. This synergistic action provides a vastly more comprehensive model for studying complex metabolic regulation than standalone GLP-1 agonists.

          ⏱️

          C20 Fatty Diacid Engineering

          Structurally modified with a highly specific C20 fatty diacid moiety. This allows tight binding to albumin in the bloodstream, heavily shielding the peptide from DPP-4 enzymatic degradation and significantly extending its half-life for prolonged studies.

          💎

          Verified High Purity (≥99.0% HPLC)

          Delivered as a sterile, lyophilized powder synthesized via state-of-the-art SPPS. This ensures maximum stability and exceptional batch-to-batch consistency, guaranteeing cellular responses are attributable solely to the Tirzepatide molecule.

          How It Works

          Tirzepatide operates as an advanced, long-acting dual receptor agonist, uniquely combining the biological mechanisms of two major incretin hormones: Glucose-dependent Insulinotropic Polypeptide (GIP) and Glucagon-Like Peptide-1 (GLP-1). In biological models, it binds directly to both receptors, unleashing a synergistic cascade of metabolic responses that are significantly more potent than targeting the GLP-1 receptor alone.

          Once activated, the dual pathway drastically improves blood glucose regulation. It powerfully stimulates insulin secretion from pancreatic beta cells in a glucose-dependent manner while simultaneously suppressing glucagon release. Crucially, the activation of the GIP receptor is believed to further enhance insulin sensitivity and directly influence lipid metabolism in white adipose tissue, leading to more efficient energy utilization.

          Beyond glycemic control, Tirzepatide exhibits profound effects on weight management. It significantly delays gastric emptying, slowing nutrient absorption. Furthermore, it crosses the blood-brain barrier to interact with neurological pathways in the hypothalamus. The synergistic engagement of GIP and GLP-1 receptors heavily amplifies satiety signals (feeling full) and suppresses appetite-stimulating neurons, leading to massive reductions in caloric intake and body mass.

          Structurally, Tirzepatide is a 39-amino acid synthetic peptide based on the native GIP sequence but heavily modified. Its key feature is the attachment of a C20 fatty diacid moiety. This critical structural addition allows the peptide to bind tightly to albumin in the bloodstream, providing near-total resistance to degradation by the DPP-4 enzyme. This drastically reduces its metabolic clearance rate, extending its half-life to approximately 5 days and providing steady, prolonged metabolic effects in research models.

          🧪 What’s In The Vial

          • Active Peptide: Highly Purified Tirzepatide
          • State: Sterile, Lyophilized Powder
          • Format: Multi-dose Research Vial
          • Net Contents: As selected (e.g., 5mg to 30mg)
          • Purity: ≥99.0% (HPLC)

          👩‍🔬 Who Uses It

          • Metabolic Disease Researchers
          • Obesity & Weight Management Labs
          • Endocrinology Specialists
          • Cardiometabolic Scientists
          • Clinical Trial Administrators

          🔗 Best Paired With

          • Sterile Bacteriostatic Water (BAC)
          • Precision Laboratory Pipettes
          • Calibrated Insulin Syringes
          • Vial Storage Organizers (-20°C)